School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

James Spivey MD

  • Department of Medicine
    Professor
  • (404) 778-3184
Head shot of James Spivey

Overview

James Spivey, MD is a professor of medicine and surgery and Vice Chair of Clinical Affairs, Department of Medicine at Emory University. Dr. Spivey started practicing medicine in 1983 and joined Emory in 2005 after 12 years in the Mayo Clinic system, where he was the founding Medical Director of the liver transplant program at the Mayo Clinic Jacksonville.

Since joining Emory, he has worked primarily to build a hepatology and liver transplant program that would serve first the state of Georgia and the southeast region of the country. Dr. Spivey earned a Certificate of Added Qualification in Transplant Hepatology in 2006.

Academic Appointment

  • Professor of Medicine, Emory University School of Medicine

Education

Degrees

  • MD from Tulane Medical School
  • BA from Hendrix College

Research

Focus

  • Treatment of Viral Hepatitis before and after Lover transplantation Evaluation and treatment of Hepatocellular Carcinoma.

Publications

  • Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
    Lancet Volume: 394 Page(s): 2184 - 2196
    12/14/2019 Authors: Younossi ZM; Ratziu V; Loomba R; Rinella M; Anstee QM; Goodman Z; Bedossa P; Geier A; Beckebaum S; Newsome PN
  • Ultrasound Elastography With Imaging: Overcoming Emerging Technology ReimbursementChallenges.
    J Am Coll Radiol Volume: 14 Page(s): 1426 - 1428
    11/01/2017 Authors: Moreno CC; Kinger N; Mittal PK; Spivey J; Baumgarten DA; Duszak R
  • Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin.
    Aliment Pharmacol Ther Volume: 45 Page(s): 1427 - 1432
    06/01/2017 Authors: Pillai AA; Maheshwari R; Vora R; Norvell JP; Ford R; Parekh S; Cheng N; Patel A; Young N; Spivey JR
  • Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
    Cardiovasc Intervent Radiol Volume: 40 Page(s): 410 - 420
    03/01/2017 Authors: Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
  • Novel role of midodrine in pulmonary hypertension in liver transplant candidates.
    Liver Transpl Volume: 22 Page(s): 1034 - 1036
    07/01/2016 Authors: Rajaram P; Spivey J; Fisher M
  • Large Single-Center Experience of Sofosbuvir and Ledipasvir Therapy for the Treatment of Post-Liver Transplant Patients with Hepatitis C Virus.
    Volume: 16 Page(s): 298 - 298
    06/01/2016 Authors: Wedd J; Ford R; Norvell J; Parekh S; Cheng N; Young N; Patel A; Maheshwari R; Vora R; Mgbemena O
  • Acute Liver Failure Due to Sickle Hepatopathy: A Role for Molecular Adsorbent Recirculation Therapy?
    Volume: 150 Page(s): S1122 - S1122
    04/01/2016 Authors: Van Leer-Greenberg BD; Mekaroonkamol P; Spivey JR; Subramanian R
  • Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.
    Gastroenterology Volume: 150 Page(s): 419 - 429
    02/01/2016 Authors: Sulkowski MS; Vargas HE; Di Bisceglie AM; Kuo A; Reddy KR; Lim JK; Morelli G; Darling JM; Feld JJ; Brown RS
  • Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    Am J Gastroenterol Volume: 111 Page(s): 250 - 260
    02/01/2016 Authors: Pillai AA; Wedd J; Norvell JP; Parekh S; Cheng N; Young N; Spivey JR; Ford R
  • Percutaneous Management of Benign Biliary Strictures with Large-Bore Catheters: Comparison between Patients with and without Orthotopic Liver Transplantation.
    J Vasc Interv Radiol Volume: 27 Page(s): 219 - 225.e1
    02/01/2016 Authors: Ludwig JM; Webber GR; Knechtle SJ; Spivey JR; Xing M; Kim HS
  • LARGE SINGLE CENTER EXPERIENCE OF SOFOSBUVIR AND LEDIPASVIR THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C VIRUS
    Volume: 64 Page(s): S780 - S780
    01/01/2016 Authors: Wedd J; Ford R; Norvell J; Parekh S; Cheng N; Young N; Patel A; Maheshwari R; Vora R; Mgbemena O
  • Prevention of Recurrent Hepatitis C in Liver Transplant (LT) Recipients with Civacir (R) : Preliminary Results on Safety and Efficacy, Including Patients with Renal/Liver Dysfunction
    Volume: 62 Page(s): 310A - 310A
    10/01/2015 Authors: Terrault N; Shrestha R; Satapathy SK; Linda S; Rosenau J; O'Leary JG; Schiano TD; Teperman LW; Spivey J; Campsen J
  • Anorexia Nervosa-Induced Hepatocyte Autophagy Resulting in Severe Acute Mixed Cholestatic and Hepatocellular Liver Injury
    Volume: 110 Page(s): S356 - S356
    10/01/2015 Authors: Mekaroonkamol P; Spivey J
  • Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
    Cancer Volume: 121 Page(s): 2164 - 2174
    07/01/2015 Authors: Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
  • Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    J Gastroenterol Hepatol Volume: 30 Page(s): 1167 - 1174
    07/01/2015 Authors: Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
  • Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
    Brain Behav Immun Volume: 46 Page(s): 17 - 22
    05/01/2015 Authors: Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
  • NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R)
    Volume: 62 Page(s): S271 - S272
    04/01/2015 Authors: Terrault N; Shrestha R; Satapathy SK; O'Leary JG; Campsen J; Rosenau J; Spivey J; Teperman LW; Therapondos G; Verna EC
  • Liver disease related to the heart.
    Transplant Rev (Orlando) Volume: 29 Page(s): 33 - 37
    01/01/2015 Authors: Ford RM; Book W; Spivey JR
  • Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    AJR Am J Roentgenol Volume: 203 Page(s): W706 - W714
    12/01/2014 Authors: Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
  • Treatment of Patients with Chronic Genotype 1 Hepatitis C With a Combination of Sofosbuvir, Simeprevir, plus /- Ribavirin at a High-Volume Academic Transplant Center
    Volume: 109 Page(s): S180 - S181
    10/01/2014 Authors: Pillai A; Ford R; Cheng N; Shah A; Norvell J; Laurence S; Young N; Parekh S; Spivey J
  • Psychosocial Determinants of Liver Transplant Access.
    Volume: 98 Page(s): 732 - 732
    07/15/2014 Authors: Levy S; Basu M; Spivey J; Patzer R
  • IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
    Neuropsychopharmacology Volume: 39 Page(s): 1777 - 1785
    06/01/2014 Authors: Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
  • Psychosocial Determinants of Liver Transplant Access.
    Volume: 14 Page(s): 732 - 732
    06/01/2014 Authors: Levy S; Basu M; Spivey J; Patzer R
  • Clinical and economic outcomes associated with medication errors in kidney transplantation.
    Clin J Am Soc Nephrol Volume: 9 Page(s): 960 - 966
    05/01/2014 Authors: Taber DJ; Spivey JR; Tsurutis VM; Pilch NA; Meadows HB; Fleming JN; McGillicuddy JW; Bratton CF; Treiber FA; Baliga PK
  • Hepatic hydrothorax.
    Clin Liver Dis Volume: 18 Page(s): 439 - 449
    05/01/2014 Authors: Norvell JP; Spivey JR
  • Recurrent Disease after Liver Transplantation
    Page(s): 869 - 882
    01/01/2014 Authors: Parekh S; Spivey JR
  • Prevention of Hepatitis C Virus (HCV) Recurrence with Peri-Transplant Hepatitis C Immune Globulin Combined with Pre-Transplant (Pre-LT) Antiviral Therapy (AVT)
    Volume: 60 Page(s): 206A - 207A
    01/01/2014 Authors: Terrault N; Satapathy SK; Therapondos G; Shrestha R; Verna EC; Campsen J; Spivey J; Rosenau J; Schiano TD; Bhamidimarri KR
  • Post-Liver Transplant Treatment of Hepatitis C with a combination of Sofosbuvir, Simeprevir, +/- Ribavirin at a High Volume Academic Transplant Center
    Volume: 60 Page(s): 701A - 701A
    01/01/2014 Authors: Ford RM; Pillai A; Cheng N; Young NM; Parekh S; Norvell JP; Subramanian R; Spivey J
  • Impact of Age on Safety and Treatment Response in Patients with Hepatitis C (HCV) Treated With Boceprevir or Telaprevir
    Volume: 58 Page(s): 218A - 218A
    10/01/2013 Authors: Aronsohn A; Stainbrook T; Mohanty S; Mubarak A; Spivey J; Pandya PK; Stewart T; Fried MW; Jacobson IM
  • Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation.
    Liver Transpl Volume: 19 Page(s): 594 - 601
    06/01/2013 Authors: Teperman LW; Poordad F; Bzowej N; Martin P; Pungpapong S; Schiano T; Flaherty J; Dinh P; Rossi S; Subramanian GM
  • Doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE) in patients with large hepatocellular carcinoma (HCC): Overall survival and a multivariate analysis (MVA) of prognostic factors.
    Volume: 31
    05/20/2013 Authors: Prajapati HJ; Spivey JR; El-Rayes BF; Kauh JS; Kim HS
  • mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).
    Ann Oncol Volume: 24 Page(s): 965 - 973
    04/01/2013 Authors: Prajapati HJ; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
  • Domino liver transplantation in maple syrup urine disease: a case report and review of the literature.
    Transplant Proc Volume: 45 Page(s): 806 - 809
    03/01/2013 Authors: Badell IR; Hanish SI; Hughes CB; Hewitt WR; Chung RT; Spivey JR; Knechtle SJ
  • Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
    Arch Gen Psychiatry Volume: 69 Page(s): 1044 - 1053
    10/01/2012 Authors: Capuron L; Pagnoni G; Drake DF; Woolwine BJ; Spivey JR; Crowe RJ; Votaw JR; Goodman MM; Miller AH
  • Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging.
    J Magn Reson Imaging Volume: 36 Page(s): 422 - 429
    08/01/2012 Authors: Martin DR; Lauenstein T; Kalb B; Lurie C; Kitajima H; Sharma P; Salman K; Moreira R; Farris AB; Spivey J
  • Massive Foveolar-Gland Polyposis of the Stomach: A Report of Three Cases of an Emerging Entity
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY Volume: 138 Page(s): A104 - A104
    07/01/2012 Authors: Gonzalez RS; Sarmiento JM; Osborn N; Keilin S; Spivey JR; Fisher K; Liu L; Bagci P; Adsay NV
  • Massive Foveolar-Gland Polyposis of the Stomach: Clinicopathologic, Histologic, and Molecular Analysis of Three Cases with Gastrectomy
    Volume: 25 Page(s): 161A - 161A
    02/01/2012 Authors: Gonzalez RS; Sarmiento JM; Osborn N; Keilin S; Spivey JR; Rossi M; Hill C; Bagci P; Adsay V
  • Massive Foveolar-Gland Polyposis of the Stomach: Clinicopathologic, Histologic, and Molecular Analysis of Three Cases with Gastrectomy
    Volume: 92 Page(s): 161A - 161A
    02/01/2012 Authors: Gonzalez RS; Sarmiento JM; Osborn N; Keilin S; Spivey JR; Rossi M; Hill C; Bagci P; Adsay V
  • Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
    Radiology Volume: 261 Page(s): 824 - 833
    12/01/2011 Authors: Becker-Weidman DJS; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV
  • MAGNETIC RESONANCE IMAGING PREDICTS SURVIVAL AFTER DOXORUBICIN DRUG ELUTING BEADS CHEMOEMBOLIZATION IN UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Volume: 54 Page(s): 900A - 901A
    10/01/2011 Authors: Prajapati HJ; Spivey J; Hanish SI; Cherr Z; El-Rayes BF; Kauh JS; Kim HS
  • Randomized Trial of Emtricitabine/Tenofovir DF +/- HBIG Withdrawal Post-Orthotopic Liver Transplantation for Chronic Hepatitis B: 48 Week Results
    Volume: 17 Page(s): S94 - S94
    06/01/2011 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Martin P; Hirsch KR; Coombs D; Anderson J
  • Randomized Trial of Emtricitabine/Tenofovir DF Plus/Minus HBIG Withdrawal in Prevention of Chronic Hepatitis B Recurrence Post-Liver Transplantation: 48 Week Results.
    Volume: 11 Page(s): 48 - 48
    04/01/2011 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Martin P; Coombs D; Hirsch KR; Anderson J
  • INTERIM 48 WEEK RESULTS OF A RANDOMIZED TRIAL OF EMTRICITABINE/TENOFOVIR DF PLUS/MINUS HBIG WITHDRAWAL IN POST-ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS FOR CHRONIC HEPATITIS B
    Volume: 54 Page(s): S234 - S234
    03/01/2011 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Martin P; Coombs D; Hirsch KR; Anderson J
  • Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.
    Biol Psychiatry Volume: 68 Page(s): 942 - 949
    11/15/2010 Authors: Raison CL; Rye DB; Woolwine BJ; Vogt GJ; Bautista BM; Spivey JR; Miller AH
  • MRI TO PRIMARILY SCREEN FOR ESOPHAGEAL VARICES IN NON-BLEEDING PATIENTS WITH CIRRHOSIS/PORTAL HYPERTENSION: A SINGLE CENTER EXPERIENCE
    Volume: 52 Page(s): 1080A - 1080A
    10/01/2010 Authors: Lom J; Parekh S; Martin DR; Spivey J; Ford RM; Kalb B
  • Beta-2-Transferrin to Detect Cerebrospinal Fluid Ascites: A Case Report
    Volume: 105 Page(s): S282 - S283
    10/01/2010 Authors: Tian C; Dbouk N; Spivey J
  • The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
    J Vasc Interv Radiol Volume: 21 Page(s): 1197 - 1204
    08/01/2010 Authors: Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
  • A Randomized Trial of HBIG Withdrawal Using Emtricitabine/Tenofovir DF in Post-Orthotopic Liver Transplant Recipients
    Volume: 16 Page(s): S70 - S70
    06/01/2010 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Pungpapong S; Martin P; Coombs D; Hirsch KR; Anderson J
  • A Randomized Trial of HBIG Withdrawal Using Emtricitabine/Tenofovir DF in Post-Liver Transplant Recipients
    Volume: 10 Page(s): 77 - 78
    04/01/2010 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Pungpapong S; Martin P; Coombs D; Hirsch KR; Anderson J
  • CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Mol Psychiatry Volume: 15 Page(s): 393 - 403
    04/01/2010 Authors: Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
  • Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
    Am J Gastroenterol Volume: 105 Page(s): 635 - 641
    03/01/2010 Authors: Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
  • EMTRICITABINE TENOFOVIR DF COMBINATION plus /- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS
    Volume: 52 Page(s): S12 - S13
    01/01/2010 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Bzowej N; Pungpapong S; Martin P; Coombs D; Hirsch KR; Anderson J
  • STIMULATION OF LIVER-RESIDENT, BUT NOT CIRCULATING PLASMACYTOID DENDRITIC CELLS WITH TOLL-LIKE RECEPTOR AGONISTS RESULTS IN HIGH LEVELS OF INTERFERON ALPHA SECRETION DURING CHRONIC HCV INFECTION
    Volume: 50 Page(s): 932A - 933A
    10/01/2009 Authors: Hon H; Shen L; Spivey JR; Kirk AD; Grakoui A
  • THE EMORY LIVER TRANSPLANT PROGRAM: EFFECTIVENESS OF A STRUCTURED COMPREHENSIVE QUALITY IMPROVEMENT INITIATIVE
    Volume: 50 Page(s): 651A - 652A
    10/01/2009 Authors: Perryman JP; Spivey J; Knechtle SJ
  • PREDICTORS OF EARLY MORTALITY AFTER TRAN-SJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS)
    Volume: 50 Page(s): 436A - 437A
    10/01/2009 Authors: Dhanasekaran R; Gonzales PC; West J; Subramanian R; Parekh S; Spivey JR; Reshamwala P; Martin LG; Kim HS
  • EMTRICITABINE/TENOFOVIR DF (FTC/TDF) FIXED DOSE COMBINATION IN PATIENTS WITH NORMAL AND IMPAIRED RENAL FUNCTION POST ORTHOTOPIC LIVER TRANSPLANT (OLT) FOR PREVENTION OF CHRONIC HEPATITIS B (CHB) RECURRENCE IN THE PRESENCE OR ABSENCE OF HBIG: UPDATED SAFETY ANALYSIS
    Volume: 15 Page(s): S118 - S118
    07/01/2009 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Coombs D; Anderson J; Oldach D; Rousseau F
  • Hepatic Masses: An Algorithmic Approach (CME Credit Available)
    Volume: 192
    05/01/2009 Authors: Krishnamoorthy S; Sebastian S; Salman K; Rostad B; Li J; Sharma P; Kalb B; Spivey J; Sarmiento J; Martin D
  • Percutaneous endoscopic holmium laser lithotripsy for management of complicated biliary calculi.
    JSLS Volume: 13 Page(s): 184 - 189
    01/01/2009 Authors: Healy K; Chamsuddin A; Spivey J; Martin L; Nieh P; Ogan K
  • Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Fixed Dose Combination in Patients with Normal and Impaired Renal Function Post-Orthotopic Liver Transplant for Prevention of Hepatitis B Recurrence in the Presence or Absence of Hepatitis B Immune Globulin (HBIG): Preliminary Safety Analysis.
    Volume: 9 Page(s): 527 - 527
    01/01/2009 Authors: Teperman L; Spivey J; Poordad F; Schiano T; Coombs D; Anderson J; Oldach D; Rousseau F
  • Concomitant hemobilia and hepatic abscess after radiofrequency ablation
    Volume: 102 Page(s): S299 - S300
    09/01/2007 Authors: Marin CS; James-Stevenson TN; Spivey JR
  • Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.
    AJR Am J Roentgenol Volume: 189 Page(s): 663 - 670
    09/01/2007 Authors: Lauenstein TC; Salman K; Morreira R; Heffron T; Spivey JR; Martinez E; Sharma P; Martin DR
  • Medical and surgical treatment of neonatal hemochromatosis: single center experience.
    Pediatr Transplant Volume: 11 Page(s): 374 - 378
    06/01/2007 Authors: Heffron T; Pillen T; Welch D; Asolati M; Smallwood G; Hagedorn P; Fasola C; Solis D; Rodrigues J; DePaolo J
  • Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation.
    Mayo Clin Proc Volume: 81 Page(s): 1029 - 1033
    08/01/2006 Authors: Hellinger WC; Bonatti H; Machicao VI; Yao JD; Brumble LM; Alvarez S; Weigand SD; Dickson RC; Harnois DM; Spivey JR
  • Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis.
    Liver Transpl Volume: 12 Page(s): 972 - 978
    06/01/2006 Authors: Heffron T; Welch D; Pillen T; Asolati M; Smallwood G; Hagedorn P; Nam C; Duncan A; Guy M; Martinez E
  • Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Liver Transpl Volume: 11 Page(s): 656 - 662
    06/01/2005 Authors: Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM
  • Gallbladder cancer and liver transplantation.
    Transpl Int Volume: 18 Page(s): 52 - 55
    01/01/2005 Authors: Schmitt TM; Hughes CB; Bonatti H; Harnois DM; Nguyen JH; Dickson RC; Spivey JR; Steers JL
  • Gallbladder cancer and liver transplantation
    Volume: 9 Page(s): C61 - C61
    06/01/2003 Authors: Schmitt TM; Bonatti H; Harnois D; Hughes CB; Nguyen JH; Dickson RC; Spivey J; Steers JL
  • Recent advances in liver transplantation.
    Mayo Clin Proc Volume: 78 Page(s): 197 - 210
    02/01/2003 Authors: Wiesner RH; Rakela J; Ishitani MB; Mulligan DC; Spivey JR; Steers JL; Krom RAF
  • Graft survival after liver transplantation is affected by donor age in hepatitis C related liver disease.
    Volume: 36 Page(s): 181A - 181A
    10/01/2002 Authors: Machicao VI; Bonatti H; Krishna M; Harnois DM; Spivey JR; Satyanaryana R; Aqel BA; Nguyen J; Hughes C; Steers JL
  • Clinical correlates of HCV genotype and viral load: Findings from the WIN-R Trial
    Volume: 36 Page(s): 376A - 376A
    10/01/2002 Authors: Jacobson I; Brown RS; Afdhal N; Rubin R; Spivey J; Freilich B; Regenstein F; Bernstein D; Doig R; Brass C
  • Characteristics of HCV infection in African-Americans: Findings from the WIN-R Trial.
    Volume: 36 Page(s): 377A - 377A
    10/01/2002 Authors: Jacobson I; Brown RS; Afdhal N; Rubin R; Spivey J; Freilich B; Regenstein F; Bernstein D; Doig R; Brass C
  • Gallbladder cancer and liver transplantation.
    Volume: 36 Page(s): 674A - 674A
    10/01/2002 Authors: Schmitt T; Bonatti H; Harnois D; Nguyen J; Hughes C; Corregidor A; Spivey JR; Machicao VI; Dickson RC; Steers DL
  • Increased tumor recurrence rate after liver transplantation for high risk hepatocellular carcinoma using grafts from older donors.
    Volume: 36 Page(s): 392A - 392A
    10/01/2002 Authors: Bonatti H; Machicao VI; Aqel A; Nguyen J; Hughes C; Spivey JR; Schmitt T; Dickson RC; Harnois D; Steers JL
  • Racial/ethnic differences in hematologic toxicity of pegylated interferon and ribavirin therapy: Analysis of the WIN-R trial.
    Volume: 36 Page(s): 292A - 292A
    10/01/2002 Authors: Brown R; Jacobson I; Afdhal N; Rubin R; Spivey J; Regenstein F; Bernstein D; Brass C; Freilich B
  • Regional and racial variation of hepatitis C genotypes in the United States.
    Volume: 36 Page(s): 711A - 711A
    10/01/2002 Authors: Balan V; Jacobson IM; Brown R; Afdhal N; Rubin R; Spivey J; Freilich B; Bernstein DE; Sharma V; Brass C
  • Portal hypertension due to hepatoportal sclerosis in a patient with HIV infection
    AMERICAN JOURNAL OF GASTROENTEROLOGY Volume: 97 Page(s): S128 - S128
    09/01/2002 Authors: Ward EM; Woodward TA; Krishna M; Spivey JR
  • Good short-term outcomes can be obtained in severely obese patients undergoing liver transplantation
    GASTROENTEROLOGY Volume: 123 Page(s): 84 - 84
    07/01/2002 Authors: Lukens FJ; Machicao VI; Dickson RC; Spivey JR; Steers JL; Harnois DM
  • A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation.
    Transplantation Volume: 73 Page(s): 1904 - 1909
    06/27/2002 Authors: Hellinger WC; Yao JD; Alvarez S; Blair JE; Cawley JJ; Paya CV; O'Brien PC; Spivey JR; Dickson RC; Harnois DM
  • Moderate to severe recurrent hepatitis C after liver transplantation in older-donor organ recipients
    GASTROENTEROLOGY Volume: 122 Page(s): A633 - A633
    04/01/2002 Authors: Machicao VI; Krishna M; Harnois DM; Lukens FJ; Aqel BA; Picco MF; Spivey JR; Steers JL; Dickson RC
  • Nutritional assessment of serum and hepatic vitamin A levels in patients with cirrhosis.
    JPEN J Parenter Enteral Nutr Volume: 26 Page(s): 184 - 188
    01/01/2002 Authors: Ukleja A; Scolapio JS; McConnell JP; Spivey JR; Dickson RC; Nguyen JH; O'Brien PC
  • Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    J Infect Dis Volume: 184 Page(s): 1461 - 1464
    12/01/2001 Authors: Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
  • Efficacy of tacrolimus in the trreatment of steroid resistant autoimmune hepatitis.
    HEPATOLOGY Volume: 34 Page(s): 302A - 302A
    10/01/2001 Authors: Aqel BA; Machicao V; Dougherty MK; Spivey JR; Harnois D; Dickson RC
  • Pegylated interferon alfa-2b and fixed versus weight-based ribavirin dosing for treatment naive patients with chronic hepatitis C.
    HEPATOLOGY Volume: 34 Page(s): 584A - 584A
    10/01/2001 Authors: Jacobson I; Brown R; Bernstein D; Bruno C; Spivey J; Lawitz E; Afdhal N; Flamm S; Freilich B; Pizov O
  • HLA-A2 in orthotopic liver transplantation
    MODERN PATHOLOGY Volume: 14 Page(s): 203A - 203A
    01/01/2001 Authors: Tennyson GS; Spivey J; Genco P
  • Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning.
    Chest Volume: 118 Page(s): 615 - 624
    09/01/2000 Authors: Krowka MJ; Wiseman GA; Burnett OL; Spivey JR; Therneau T; Porayko MK; Wiesner RH
  • A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation.
    Am J Ophthalmol Volume: 129 Page(s): 536 - 538
    04/01/2000 Authors: Brazis PW; Spivey JR; Bolling JP; Steers JL
  • Interferon alpha 2b 5MU TIW with or without ribavirin as initial treatment for hepatitis C.
    HEPATOLOGY Volume: 30 Page(s): 634A - 634A
    10/01/1999 Authors: Gross JB; Lindor KD; Abdelmalek MF; Poterucha JJ; Brandhagen DJ; Czaja AJ; Czaplewski LA; Bode DM; Gossard AG; Therneau TM
  • Interferon alpha 2B 5MU TIW, +/- 4-week daily interferon induction, +/- ribavirin, for re-treatment of interferon non-responders with chronic hepatitis C.
    HEPATOLOGY Volume: 30 Page(s): 634A - 634A
    10/01/1999 Authors: Gross JB; Brandhagen DJ; Poterucha JJ; Lindor KD; Douglas DD; Spivey JR; Peine C; Rank J; Czaplewski LA; Gossard AA
  • Daily interferon to suppress HCV viremia among interferon non-responders.
    HEPATOLOGY Volume: 28 Page(s): 573A - 573A
    10/01/1998 Authors: Gross JB; Brandhagen DJ; Gossard AA; Poterucha JJ; Douglas DD; Spivey JR; Peine C; Smith T
  • Hemobilia due to hepatic artery pseudoaneurysm thirteen months after laparoscopic cholecystectomy (vol 26, pg 50, 1998)
    JOURNAL OF CLINICAL GASTROENTEROLOGY Volume: 26 Page(s): 359 - 359
    06/01/1998 Authors: Ribeiro A; Williams H; May G; Fulmer JT; Spivey JR
  • Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
    J Clin Gastroenterol Volume: 26 Page(s): 130 - 134
    03/01/1998 Authors: Abdelmalek MF; Harrison ME; Gross JB; Poterucha JJ; Gossard AA; Spivey JR; Rakela J; Lindor KD
  • Hemobilia due to hepatic artery pseudoaneurysm thirteen months after laparoscopic cholecystectomy.
    J Clin Gastroenterol Volume: 26 Page(s): 50 - 53
    01/01/1998 Authors: Ribeiro A; Williams H; May G; Fulmer JT; Spivey JR
  • Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: A randomized prospective trial.
    GASTROENTEROLOGY Volume: 112 Page(s): A1205 - A1205
    04/01/1997 Authors: Abdelmalek MF; Lindor KD; Harrison ME; Spivey JR; Gross JB; Poterucha JJ; Czaja AJ; Gossard AA
  • RESPONSE TO 100-PERCENT INSPIRED OXYGEN IN PATIENTS WITH HEPATOPULMONARY SYNDROME
    HEPATOLOGY Volume: 22 Page(s): 1339 - 1339
    10/01/1995 Authors: KROWKA MJ; CASTRO M; CORTESE DA; SPIVEY JR
  • Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.
    J Pharmacol Exp Ther Volume: 272 Page(s): 930 - 938
    02/01/1995 Authors: Botla R; Spivey JR; Aguilar H; Bronk SF; Gores GJ
  • The hydrophobic bile salt as an agent of mitochondrial toxicity
    Volume: 80 Page(s): 290 - 297
    01/01/1995 Authors: Spivey JR; Botla R; Bronk SF; Gores GJ
  • Apoptosis - An alternative mechanism of bile salt hepatotoxicity
    Volume: 82 Page(s): 88 - 95
    01/01/1995 Authors: Patel T; Spivey J; Vadakekalam J; Gores GJ
  • Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis.
    Am J Gastroenterol Volume: 89 Page(s): 2028 - 2032
    11/01/1994 Authors: Spivey JR; Jorgensen RA; Gores GJ; Lindor KD
  • URSODEOXYCHOLATE INHIBITS THE MITOCHONDRIAL-MEMBRANE PERMEABILITY TRANSITION (MMPT) INDUCED BY GLYCOCHENODEOXYCHOLATE - A MECHANISM FOR URSODEOXYCHOLATE CYTOPROTECTION
    HEPATOLOGY Volume: 20 Page(s): A175 - A175
    10/01/1994 Authors: BOTLA R; SPIVEY JR; BRONK SF; GORES GJ
  • RANDOMIZED STUDY OF HIGH-DOSE VERSUS LOW-DOSE FK-506 FOLLOWING LIVER-TRANSPLANTATION
    HEPATOLOGY Volume: 18 Page(s): A74 - A74
    10/01/1993 Authors: SPIVEY J; PORAYKO M; HAY E; GORES G; STEERS J; KROM R; WIESNER R
  • Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.
    J Clin Invest Volume: 92 Page(s): 17 - 24
    07/01/1993 Authors: Spivey JR; Bronk SF; Gores GJ
  • TAUROURSODEOXYCHOLATE PREVENTS GLYCOCHENODEOXYCHOLATE INDUCED NONLYSOSOMAL PROTEOLYSIS AND CYTOTOXICITY IN ISOLATED RAT HEPATOCYTES
    HEPATOLOGY Volume: 16 Page(s): A156 - A156
    10/01/1992 Authors: SPIVEY JR; BRONK SF; GORES GJ
  • Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members.
    Hepatology Volume: 16 Page(s): 899 - 905
    10/01/1992 Authors: Caldwell SH; Leung PS; Spivey JR; Prindiville T; de Medina M; Saicheur T; Rowley M; Reddy KR; Coppel R; Jeffers LJ
  • URSODEOXYCHOLATE CYTOPROTECTION AGAINST HEPATOCYTE KILLING BY HYDROPHOBIC BILE-SALTS CANNOT BE EXPLAINED SOLELY BY CHANGES IN THE HYDROPHOBICITY INDEX
    HEPATOLOGY Volume: 16 Page(s): A134 - A134
    10/01/1992 Authors: SPIVEY JR; VADAKEKALAM J; GORES GJ
  • Risk factors and screening for hepatocellular carcinoma.
    Compr Ther Volume: 18 Page(s): 5 - 9
    06/01/1992 Authors: Spivey JR; Gores GJ
  • ERCP documentation of obstructive jaundice caused by a solitary, centrally located, benign hepatic cyst.
    Gastrointest Endosc Volume: 36 Page(s): 521 - 523
    01/01/1990 Authors: Spivey JR; Garrido JA; Reddy KR; Jeffers LJ; Schiff ER
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements